JenaValve Gets CE Mark For TAVI Device In Europe

By Adam Pick on October 5, 2011

As patients in the United States continue to wait for FDA approval of transcatheter aortic valve replacement devices, another TAVI technology just received a CE mark for commercial use in Europe.

Jena TAVI - Aortic Valve Replacement Via Catheter
JenaValve TAVI – Aortic Valve Replacement Via Catheter

Earlier today, JenaValve Technology, a medical device manufacturer in Germany, announced its receipt of a CE mark for its 2nd-generation transapical TAVI system. As you may know, these technological breakthroughs are used to treat patients with severe aortic valve stenosis who are considered “inoperable” or too “high-risk” for surgery.

Using the JenaValve, a patient’s diseased aortic valve can be replaced without traditional surgical procedures that use incisions to the sternum (sternotomy) or ribs (thoracotomy).

Jena Valve TAVI
The JenaValve & Its Delivery System

Reflecting upon this announcement, Prof. Dr. Friedrich-Wilhelm Mohr, Medical Director of the Department of Cardiac Surgery at the University of Leipzig Heart Center, noted:

“Now patients have access to a new generation system for transapical TAVI treatment. The JenaValve design allows the cardiac surgeon and cardiologist to achieve precise positioning and allows repositioning of the heart valve prosthesis with its unique, patented positioning feelers. It is with these key features that the system distinguishes itself from its competitors,” — Prof. Mohr.

If you are curious, there are several competitors to the JenaValve, including the Edwards SAPIEN Valve and the CoreValve by Medtronic. Both devices have CE marks in Europe but have yet to receive FDA approval in the United States.

Considering the excitement regarding catheter-based technologies for heart valve treatment, I will continue to monitor this topic. So, stay tuned!

Keep on tickin!


Written by Adam Pick
- Patient & Website Founder

Adam Pick is a heart valve patient and author of The Patient's Guide To Heart Valve Surgery. In 2006, Adam founded HeartValveSurgery.com to educate and empower patients. This award-winning website has helped over 10 million people fight heart valve disease. Adam has been featured by the American Heart Association and The Wall Street Journal.

Adam Pick is a heart valve patient and author of The Patient's Guide To Heart Valve Surgery. In 2006, Adam founded HeartValveSurgery.com to educate and empower patients. This award-winning website has helped over 10 million people fight heart valve disease. Adam has been featured by the American Heart Association and The Wall Street Journal.

Adam's Newest Blogs

Adam's Newest Posts

Breakthrough Discovery: INSPIRIS RESILIA Aortic Valve Approved by the FDA Learn More.

We Rise To #2 On Feedspot’s 2018 Top Heart Blogs & Websites Rankings! Learn More.

New Community Posts

Sue says, "Cardiac cath via groin went smoothly..."
Read more

Sue says, "I'm curous to know if people with..."
Read more

Newest Community Post

Sue says, "Cardiac cath via groin went smoothly"
Read more

Sue says, "I'm curous to know if people with"
Read more

MARIE says, "Moving alone, so far I had a my CT scan"
Read more

Find Heart Valve Surgeons

Search 1,500 patient-recommended surgeons